Human papillomavirus type 52 infection

Human papillomavirus type 52 infection has been studied in 2 papers since 2016: 2 observational studies in people; 1 in the past year. The newest paper, Dec 16, 2025: “Factors related to cervicogenital high-risk human papillomavirus persistence among Chinese women: a nationwide multi-center cohort study”.

Exposure

2 papers study it1 findingUpdated

See all 2 papers on human papillomavirus type 52 infection

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: National Natural Science Foundation of China and 1 more
  • Humans2

What is human papillomavirus type 52 infection linked with?

1

Studies link human papillomavirus type 52 infection with 3-year HR-HPV persistence.

3-year HR-HPV persistence

upin humans1OR 1.95

1 study
  1. Human papillomavirus type 52 infection is associated with 3-year HR-HPV persistence in humans (HR-HPV positive at baseline) (OR 1.95, 95% CI 1.45–2.64).

    HumansHR-HPV positive at baseline3 yearsfemalesn = 1,684

More on 3-year HR-HPV persistence

Latest

Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months